Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jamie L Feldman is active.

Publication


Featured researches published by Jamie L Feldman.


International Journal of Transgenderism | 2012

Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7

Eli Coleman; Walter O. Bockting; M. Botzer; Peggy T. Cohen-Kettenis; G. DeCuypere; Jamie L Feldman; L. Fraser; Jamison Green; Gail Knudson; Walter J. Meyer; Stan Monstrey; R. K. Adler; George R. Brown; Aaron H. Devor; R. Ehrbar; Randi Ettner; E. Eyler; Robert Garofalo; Dan H. Karasic; A. I. Lev; G. Mayer; B. P. Hall; F. Pfaefflin; K. Rachlin; Beatrice “Bean” E. Robinson; L. S. Schechter; Vin Tangpricha; M. van Trotsenburg; A. Vitale; Sam Winter

ABSTRACT The Standards of Care (SOC) for the Health of Transsexual, Transgender, and Gender Nonconforming People is a publication of the World Professional Association for Transgender Health (WPATH). The overall goal of the SOC is to provide clinical guidance for health professionals to assist transsexual, transgender, and gender nonconforming people with safe and effective pathways to achieving lasting personal comfort with their gendered selves, in order to maximize their overall health, psychological well-being, and self-fulfillment. This assistance may include primary care, gynecologic and urologic care, reproductive options, voice and communication therapy, mental health services (e.g., assessment, counseling, psychotherapy), and hormonal and surgical treatments. The SOC are based on the best available science and expert professional consensus. Because most of the research and experience in this field comes from a North American and Western European perspective, adaptations of the SOC to other parts of the world are necessary. The SOC articulate standards of care while acknowledging the role of making informed choices and the value of harm reduction approaches. In addition, this version of the SOC recognizes that treatment for gender dysphoria i.e., discomfort or distress that is caused by a discrepancy between persons gender identity and that persons sex assigned at birth (and the associated gender role and/or primary and secondary sex characteristics) has become more individualized. Some individuals who present for care will have made significant self-directed progress towards gender role changes or other resolutions regarding their gender identity or gender dysphoria. Other individuals will require more intensive services. Health professionals can use the SOC to help patients consider the full range of health services open to them, in accordance with their clinical needs and goals for gender expression.


International Journal of Transgenderism | 2006

Physical Aspects of Transgender Endocrine Therapy

Marshall Dahl; Jamie L Feldman; Joshua M. Goldberg; Afshin Jaberi

SUMMARY The goal of transgender endocrine therapy is to change secondary sex characteristics to reduce gender dysphoria and/or facilitate gender presentation that is consistent with the felt sense of self. To maximize desired effects and minimize adverse effects, endocrine therapy must be individualized based on the patients goals, the risk/benefit ratio of medications, the presence of other medical conditions, and consideration of social and economic issues. In this article we suggest protocols for the prescribing clinician relating to physical assessment, prescription planning, initiation of endocrine therapy, and ongoing maintenance in transgender adults.


Current Opinion in Endocrinology, Diabetes and Obesity | 2016

Barriers to healthcare for transgender individuals.

Joshua D. Safer; Eli Coleman; Jamie L Feldman; Robert Garofalo; Wylie C. Hembree; Asa Radix; Jae Sevelius

Purpose of reviewTransgender persons suffer significant health disparities and may require medical intervention as part of their care. The purpose of this manuscript is to briefly review the literature characterizing barriers to healthcare for transgender individuals and to propose research priorities to understand mechanisms of those barriers and interventions to overcome them. Recent findingsCurrent research emphasizes sexual minorities’ self-report of barriers, rather than using direct methods. The biggest barrier to healthcare reported by transgender individuals is lack of access because of lack of providers who are sufficiently knowledgeable on the topic. Other barriers include: financial barriers, discrimination, lack of cultural competence by providers, health systems barriers, and socioeconomic barriers. SummaryNational research priorities should include rigorous determination of the capacity of the US healthcare system to provide adequate care for transgender individuals. Studies should determine knowledge and biases of the medical workforce across the spectrum of medical training with regard to transgender medical care; adequacy of sufficient providers for the care required, larger social structural barriers, and status of a framework to pay for appropriate care. As well, studies should propose and validate potential solutions to address identified gaps.


International Journal of Transgenderism | 2006

Transgender Primary Medical Care

Jamie L Feldman; Joshua M. Goldberg

SUMMARY Transgender medical care involves addressing general medical conditions and those related specifically to transgender issues. This article summarizes existing research in transgender medicine and provides guidance for family physicians and nurses in adapting standard primary care protocols relating to health maintenance, acute illness, and chronic disease management to address trans-specific clinical oncerns. Trans-specific issues in physical examination, health history, interpretation of laboratory tests, vaccination, screening, and treatment are explored, and the role of the primary care provider in caring for patients undergoing hormonal or surgical change is discussed.


Current Opinion in Endocrinology, Diabetes and Obesity | 2016

Advancing methods for US transgender health research

Sari L. Reisner; Madeline B. Deutsch; Shalender Bhasin; Walter Bockting; George R. Brown; Jamie L Feldman; Robert Garofalo; Baudewijntje P.C. Kreukels; Asa Radix; Joshua D. Safer; Vin Tangpricha; Guy T'Sjoen; Michael Goodman

Purpose of reviewThis article describes methodological challenges, gaps, and opportunities in US transgender health research. Recent findingsLack of large prospective observational studies and intervention trials, limited data on risks and benefits of sex affirmation (e.g., hormones and surgical interventions), and inconsistent use of definitions across studies hinder evidence-based care for transgender people. Systematic high-quality observational and intervention-testing studies may be carried out using several approaches, including general population-based, health systems-based, clinic-based, venue-based, and hybrid designs. Each of these approaches has its strength and limitations; however, harmonization of research efforts is needed. Ongoing development of evidence-based clinical recommendations will benefit from a series of observational and intervention studies aimed at identification, recruitment, and follow-up of transgender people of different ages, from different racial, ethnic, and socioeconomic backgrounds and with diverse gender identities. SummaryTransgender health research faces challenges that include standardization of lexicon, agreed upon population definitions, study design, sampling, measurement, outcome ascertainment, and sample size. Application of existing and new methods is needed to fill existing gaps, increase the scientific rigor and reach of transgender health research, and inform evidence-based prevention and care for this underserved population.


Current Opinion in Endocrinology, Diabetes and Obesity | 2016

Priorities for transgender medical and healthcare research.

Jamie L Feldman; George R. Brown; Madeline B. Deutsch; Wylie C. Hembree; Walter J. Meyer; Vin Tangpricha; Guy T'Sjoen; Joshua D. Safer

Purpose of reviewTransgender individuals experience unique health disparities but are the subject of little focused health research. This manuscript reviews current literature on transgender medical and mental health outcomes and proposes research priorities to address knowledge gaps. Recent findingsPublished research in transgender healthcare consists primarily of case reports, retrospective and cross-sectional studies, involving largely European settings. Challenges to US-based transgender health research include a diverse population where no single center has sufficient patient base to conduct clinical research with statistical rigor. Treatment regimens are heterogeneous and warrant study for best practices. Current research suggests increased mortality and depression in transgender individuals not receiving optimal care, and possibly a modest increase in cardiovascular risk related to hormone therapy. Current evidence does not support concerns for hormone-related malignancy risk. SummaryThe priorities for transgender medical outcomes research should be to determine health disparities and comorbid health conditions over the life span, along with the effects of mental health, medical, and surgical interventions on morbidity and mortality. Specific outcomes of interest based on frequency in the literature, potential severity of outcome, and patient-centered interest, include affective disorders, cardiovascular disease, malignancies, fertility, and time dose-related responses of specific interventions.


Journal of Homosexuality | 2014

HIV Risk Behaviors in the U.S. Transgender Population: Prevalence and Predictors in a Large Internet Sample

Jamie L Feldman; Rebecca Swinburne Romine; Walter Bockting

To study the influence of gender on HIV risk, a sample of the U.S. transgender population (N = 1,229) was recruited via the Internet. HIV risk and prevalence were lower than reported in prior studies of localized, urban samples but higher than the overall U.S. population. Findings suggest that gender nonconformity alone does not itself result in markedly higher HIV risk. Sex with nontransgender men emerged as the strongest independent predictor of unsafe sex for both male-to-female (MtF) and female-to-male (FtM) participants. These sexual relationships constitute a process that may either affirm or problematize gender identity and sexual orientation, with different emphases for MtFs and FtMs, respectively.


International Journal of Transgenderism | 2009

Hormone Therapy in Adults: Suggested Revisions to the Sixth Version of the Standards of Care

Jamie L Feldman; Joshua D. Safer

ABSTRACT Often viewed as the definitive professional document on transgender care, the current Standards of Care for Gender Identity Disorders—Sixth Version provides a general overview of the risks and effects of adult hormone therapy, but at present offers limited guidance for the medical provider as to how best to execute this critical intervention. Newer versions need to present a comprehensive approach to transgender hormone therapy, including preventive health care, by incorporating the following key elements: the prescribing physicians responsibilities, clinical situations for hormone therapy, effects and risks of hormone therapy, assessment for initiating hormone therapy, monitoring hormone therapy, and suggested hormone regimens.


Journal of the American College of Cardiology | 2013

Sexual function after left ventricular assist device.

Peter Eckman; Vinayak Dhungel; Stacy Mandras; Meredith A. Brisco; S. Emani; Sue Duval; JoAnn Lindenfeld; Nasir Z. Sulemanjee; George Sokos; Jamie L Feldman

To the Editor: Impaired sexual function is common in patients with heart failure ([1][1]) and following cardiac transplant. Left ventricular assist devices (LVADs) improve survival, functional capacity, and quality of life for end-stage heart failure, but data regarding their impact on sexual


Canadian Medical Association Journal | 2014

Gender dysphoria in a 39-year-old man

Jamie L Feldman; Katherine G. Spencer

A 39-year-old married man with a history of depression presents to his primary physician requesting estrogen. He explains that he has felt “more like a girl” since his early teen years and states that he can no longer tolerate living this way. A physical examination shows mild gynecomastia and

Collaboration


Dive into the Jamie L Feldman's collaboration.

Top Co-Authors

Avatar

George R. Brown

East Tennessee State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert Garofalo

Children's Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gail Knudson

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Eli Coleman

University of Minnesota

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Walter J. Meyer

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marshall Dahl

University of British Columbia

View shared research outputs
Researchain Logo
Decentralizing Knowledge